MRKR

HEALTHCARE

Marker Therapeutics Inc

$1.46-0.05 (-3.31%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving MRKR Today?

No stock-specific AI insight has been generated for MRKR yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$0.81$2.46

$1.46

Fundamentals

Market Cap$24M

P/E Ratio—

EPS$-0.79

Dividend Yield—

Dividend / Share—

ROE-0.7%

Profit Margin—

Debt / Equity—

Trading

Volume79K

Avg Volume (10D)—

Shares Outstanding16.7M

MRKR News

20 articles

All 20 articles loaded

Price Data

Open$1.52

Previous Close$1.51

Day High$1.54

Day Low$1.46

52 Week High$2.46

52 Week Low$0.81

52-Week Range

$0.81$2.46

$1.46

Fundamentals

Market Cap$24M

P/E Ratio—

EPS$-0.79

Dividend Yield—

Dividend / Share—

ROE-0.7%

Profit Margin—

Debt / Equity—

Trading

Volume79K

Avg Volume (10D)—

Shares Outstanding16.7M

About Marker Therapeutics Inc

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas.

markertherapeutics.com

5 employees

Listed January 7, 1998

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—